- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 inflammasome in hepatic diseases: A pharmacological target
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume 217, Issue -, Pages 115861
Publisher
Elsevier BV
Online
2023-10-18
DOI
10.1016/j.bcp.2023.115861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: A systematic review of implications on health effects
- (2023) Taotao Wang et al. FOOD RESEARCH INTERNATIONAL
- Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
- (2023) Ashraf Elbahrawy et al. Viruses-Basel
- Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating TLR4-NF-κB-MAPK inflammatory response in mice
- (2023) Xing-Ling Shen et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals
- (2023) Pablo Muriel et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome
- (2023) Qi Shen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword
- (2023) Ying-Le Tang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Activated Hepatic Stellate Cells (Ito Cells) - Marker of Advanced Fibrosis in Chronic Viral Hepatitis C: A Pilot Study
- (2023) Rada Teodora Sufletel et al. Journal of Gastrointestinal and Liver Diseases
- Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review
- (2023) Kuan-Hsuan Huang et al. MEDICINE
- The role of NLRP3 inflammasome in hepatocellular carcinoma
- (2023) Huijie Zhao et al. Frontiers in Pharmacology
- Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway
- (2023) Irina Cardoso-Lezama et al. BIOCHEMICAL PHARMACOLOGY
- Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease
- (2023) Annabelle S Chidiac et al. Expert Opinion on Drug Metabolism & Toxicology
- Analysis of hepatocellular carcinoma associated with hepatitis B virus
- (2023) Litao Zheng JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid
- (2023) Alma Čypienė et al. Nutrients
- The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
- (2023) Shahrzad Shoraka et al. Frontiers in Microbiology
- T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values
- (2023) Pooria Fazeli et al. Frontiers in Immunology
- Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma
- (2023) Zhuoran Wang et al. Frontiers in Oncology
- Role of NLRP3 inflammasome activation in HCC cell progression
- (2023) Bingling Dai et al. Heliyon
- Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
- (2022) Mattia Spano et al. Nutrients
- Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
- (2022) Konstantinos Arvanitakis et al. Cancers
- Curcumin mitigates aflatoxin B1-induced liver injury via regulating the NLRP3 inflammasome and Nrf2 signaling pathway
- (2022) Yingjie Wang et al. FOOD AND CHEMICAL TOXICOLOGY
- NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
- (2022) Yue Ding et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dimethyl fumarate ameliorates autoimmune hepatitis in mice by blocking NLRP3 inflammasome activation
- (2022) Fu-li Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy
- (2022) Hyon K. Choi et al. Nature Reviews Rheumatology
- Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway
- (2022) Xiujing Dou et al. Nutrients
- The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
- (2022) Stavros P. Papadakos et al. Cancers
- NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
- (2022) Yanling Guan et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model
- (2022) Eduardo E. Vargas-Pozada et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-18 in metabolism: From mice physiology to human diseases
- (2022) Emmanuel Somm et al. Frontiers in Endocrinology
- Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism
- (2022) Songsong Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL/6 mice
- (2022) Thi My Tien Truong et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis
- (2022) Tania Guadalupe Heredia-Torres et al. Viruses-Basel
- Inhibition of hepatic NLRP3 inflammasome ameliorates non-alcoholic steatohepatitis/hepatitis B - induced hepatic injury
- (2022) Feng Chen et al. Clinics and Research in Hepatology and Gastroenterology
- Significance of elevated serum and hepatic NOD-like receptor pyrin domain containing 3 (NLRP3) in hepatitis C virus-related liver disease
- (2022) Hoda El Aggan et al. Scientific Reports
- Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome
- (2021) Sonia Marinho et al. Biomolecules
- Bavachin enhances NLRP3 inflammasome activation induced by ATP or nigericin and causes idiosyncratic hepatotoxicity
- (2021) Nan Qin et al. Frontiers of Medicine
- Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
- (2021) Guang-Ming Ren et al. Science Immunology
- Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies
- (2021) Mohammad Ghanbari et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial
- (2021) Zahra Namkhah et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B
- (2021) Hwan Hee Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fructose and the Liver
- (2021) Pablo Muriel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 β and regulating downstream CD40-CD40L signaling
- (2021) Zenghui Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Role of the Inflammasome in Liver Disease
- (2021) Marcelle de Carvalho Ribeiro et al. Annual Review of Pathology-Mechanisms of Disease
- FNDC5 induces M2 macrophage polarization and promotes hepatocellular carcinoma cell growth by affecting the PPARγ/NF-κB/NLRP3 pathway
- (2021) Huayuan Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial
- (2021) Fatemeh Naeini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A new perspective on NAFLD: Focusing on lipid droplets
- (2021) Eleonora Scorletti et al. JOURNAL OF HEPATOLOGY
- Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study
- (2021) Xuan Zhu et al. Clinics and Research in Hepatology and Gastroenterology
- Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD
- (2020) Andreea-Manuela Mirea et al. INFLAMMATION
- Pterostilbene Improves Hepatic Lipid Accumulation via the MiR-34a/Sirt1/SREBP-1 Pathway in Fructose-Fed Rats
- (2020) Wen-Yuan Wu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
- (2020) Sudeep Tanwar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- RIPK3 orchestrates fatty acid metabolism in tumor-associated macrophages and hepatocarcinogenesis
- (2020) Lei Wu et al. Cancer Immunology Research
- Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice
- (2020) Lívia Pimentel de Sant'Ana et al. Frontiers in Immunology
- Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation
- (2020) Wen-hui Xie et al. INFLAMMATION RESEARCH
- NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF
- (2020) Yanhong Jia et al. MOLECULAR IMMUNOLOGY
- FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
- (2020) Jun Jacob Hu et al. NATURE IMMUNOLOGY
- Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
- (2020) Wei Shi et al. Cell Death & Disease
- Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease
- (2020) Maria V. Irazabal et al. Cells
- NLRP6 exerts a protective role via NF-kB with involvement of CCL20 in a mouse model of alcoholic hepatitis
- (2020) Xiaoyu Ji et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial
- (2020) Zahra Yari et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Baicalin promotes liver regeneration after acetaminophen-induced liver injury by inducing NLRP3 inflammasome activation
- (2020) Liang Shi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
- (2020) Susanne Gaul et al. JOURNAL OF HEPATOLOGY
- Metabolic liver disease in diabetes – From mechanisms to clinical trials
- (2020) Bedair Dewidar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis
- (2020) Bernat Baeza-Raja et al. PLoS One
- Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis
- (2020) Antje Mohs et al. JOURNAL OF HEPATOLOGY
- Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
- (2020) Marina Galicia-Moreno et al. Antioxidants
- NLRP3 inflammasome inhibitor CY-09 reduces hepatic steatosis in experimental NAFLD mice
- (2020) Xianfei Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
- (2020) Yunfan Sun et al. CELL
- Lactate and TGF‐β antagonistically regulate inflammasome activation in the tumor microenvironment
- (2020) Cheng‐e Tu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
- (2020) Erika Ramos-Tovar et al. Antioxidants
- Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway
- (2020) Koji Ishida et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Sestrin2 protects against bavachin induced ER stress through AMPK/mTORC1 signaling pathway in HepG2 cells
- (2020) Ying Yang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Systematic Review of Published Data on Herb Induced Liver Injury
- (2019) Jung-Hwan Byeon et al. JOURNAL OF ETHNOPHARMACOLOGY
- Trichloroethene metabolite dichloroacetyl chloride induces apoptosis and compromises phagocytosis in Kupffer Cells: Activation of inflammasome and MAPKs
- (2019) Hui Wang et al. PLoS One
- Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation
- (2019) Amina A. Negash et al. PLoS Pathogens
- Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis
- (2019) Ning-Ping Zhang et al. LABORATORY INVESTIGATION
- Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner
- (2019) Raphael Meier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- rhIL-1Ra reduces hepatocellular apoptosis in mice with acute liver failure mainly by inhibiting the activities of Kupffer cells
- (2019) Xiaolan Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
- (2019) Zoltán Szekanecz et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Microbiota as a cornerstone in the development of primary sclerosing cholangitis: paving the path for translational diagnostic and therapeutic approaches
- (2019) Catherine Mooser et al. GUT
- Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high‐fat high cholesterol diet via regulating NF‐κB and NLRP3 inflammasome pathway
- (2019) Yuanling Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hepatitis B core antigen can regulate NLRP3 inflammasome pathway in HepG2 cells
- (2019) Xiaolin Ding et al. JOURNAL OF MEDICAL VIROLOGY
- British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis
- (2019) Michael Huw Chapman et al. GUT
- Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
- (2019) Aleksandar Arsenijevic et al. Frontiers in Immunology
- Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
- (2019) Erika Ramos‐Tovar et al. JOURNAL OF APPLIED TOXICOLOGY
- Host inflammasome defense mechanisms and bacterial pathogen evasion strategies
- (2019) Susan M Brewer et al. CURRENT OPINION IN IMMUNOLOGY
- Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity
- (2019) Hui Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress
- (2019) Shi Zilu et al. Aging-US
- Herbal medicines for the liver
- (2019) Eduardo E. Vargas-Pozada et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Efficacy of phytosomal curcumin among patients with non-alcoholic fatty liver disease
- (2019) Seyed Reza Mirhafez et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Clinicopathological features of Bu Gu Zhi‐induced liver injury, a long‐term follow‐up cohort study
- (2019) Lan Wang et al. LIVER INTERNATIONAL
- NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway
- (2019) Durgesh Kumar Dwivedi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC
- (2018) Liang Shi et al. BIOCHEMICAL PHARMACOLOGY
- Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice
- (2018) Xianhong Du et al. Cellular & Molecular Immunology
- Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
- (2018) Paschalis Paschos et al. Current Vascular Pharmacology
- The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation
- (2018) Adam Molyvdas et al. CYTOKINE
- Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression
- (2018) Mi Jeong Heo et al. GUT
- Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
- (2018) Jingying Zhang et al. HEPATOLOGY
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
- (2018) Bing Xu et al. JOURNAL OF HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Globalization and the Changing Epidemiology of Hepatitis A Virus
- (2018) Kathryn H. Jacobsen Cold Spring Harbor Perspectives in Medicine
- NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis
- (2018) Jingyun Luan et al. Frontiers in Immunology
- Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release
- (2018) Junjiang Pan et al. CELLULAR IMMUNOLOGY
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- Mitochondrial dysfunction-related lipid changes occur in non-alcoholic fatty liver disease progression
- (2018) Kang-Yu Peng et al. JOURNAL OF LIPID RESEARCH
- New mitochondrial DNA synthesis enables NLRP3 inflammasome activation
- (2018) Zhenyu Zhong et al. NATURE
- Alcoholic liver disease
- (2018) Helmut K. Seitz et al. Nature Reviews Disease Primers
- Repression of TXNIP-NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis
- (2018) Ru-Xue Bai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
- (2017) Lars Aabakken et al. ENDOSCOPY
- Hepatic nucleotide binding oligomerization domain- like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease
- (2017) Hironori Mitsuyoshi et al. HEPATOLOGY RESEARCH
- NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid
- (2017) Can Cai et al. INFLAMMATION
- Inflammasome activation and assembly at a glance
- (2017) Ankit Malik et al. JOURNAL OF CELL SCIENCE
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
- (2017) Wen-Jun Su et al. Journal of Neuroinflammation
- Clinical Trial Design for Alcoholic Hepatitis
- (2017) Gyongyi Szabo SEMINARS IN LIVER DISEASE
- Mitochondrial ROS induced by chronic ethanol exposure promote hyper-activation of the NLRP3 inflammasome
- (2017) Laura R. Hoyt et al. Redox Biology
- Hepatitis C virus infection
- (2017) Michael P. Manns et al. Nature Reviews Disease Primers
- Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD
- (2017) Irene Pierantonelli et al. Scientific Reports
- BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination
- (2017) Do-Wan Shim et al. Scientific Reports
- Angiotensin-(1–7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation
- (2016) Shuang-Ming Cai et al. ANTIOXIDANTS & REDOX SIGNALING
- Galectin-3 regulates inflammasome activation in cholestatic liver injury
- (2016) Jijing Tian et al. FASEB JOURNAL
- Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease
- (2016) Terence N. Bukong et al. HEPATOLOGY
- Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
- (2016) Chuansheng Guo et al. IMMUNITY
- K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
- (2016) Christina J. Groß et al. IMMUNITY
- Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism
- (2016) Xingyong Wan et al. JOURNAL OF HEPATOLOGY
- Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
- (2016) Sepideh Rahmani et al. PHYTOTHERAPY RESEARCH
- Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
- (2016) Te-Sheng Chang et al. PLoS One
- Hepatitis E vaccine: WHO position paper, May 2015 – Recommendations
- (2016) WHO VACCINE
- Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model
- (2016) Chia-Chih Liao et al. PLoS One
- Experimental models of liver fibrosis
- (2015) Sara Crespo Yanguas et al. ARCHIVES OF TOXICOLOGY
- Macrophage autophagy protects against liver fibrosis in mice
- (2015) Jasper Lodder et al. Autophagy
- Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice
- (2015) Arvin Iracheta-Vellve et al. JOURNAL OF HEPATOLOGY
- Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice
- (2015) Kele Cui et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Autoimmune hepatitis
- (2015) JOURNAL OF HEPATOLOGY
- Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease
- (2015) Jan Petrasek et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Silymarin Inhibits the Progression of Fibrosis in the Early Stages of Liver Injury in CCl4-Treated Rats
- (2015) Simona Clichici et al. JOURNAL OF MEDICINAL FOOD
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- ER stress induces NLRP3 inflammasome activation and hepatocyte death
- (2015) C Lebeaupin et al. Cell Death & Disease
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
- (2014) George N. Ioannou et al. JOURNAL OF LIPID RESEARCH
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Alcohol withdrawal alleviates adipose tissue inflammation in patients with alcoholic liver disease
- (2014) Cosmin S. Voican et al. LIVER INTERNATIONAL
- Rutin modulates ASC expression in NLRP3 inflammasome: a study in alcohol and cerulein-induced rat model of pancreatitis
- (2014) Ravikumar Aruna et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Luteoloside Suppresses Proliferation and Metastasis of Hepatocellular Carcinoma Cells by Inhibition of NLRP3 Inflammasome
- (2014) Shao-hua Fan et al. PLoS One
- A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States
- (2014) Marissa Blieden et al. Expert Review of Clinical Pharmacology
- Mechanism of interleukin-1β-induced proliferation in rat hepatic stellate cells from different levels of signal transduction
- (2013) Zhang Yaping et al. APMIS
- Psoralea corylifolia L. (Buguchi) — Folklore to modern evidence: Review
- (2013) Bhawna Chopra et al. FITOTERAPIA
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
- (2013) Alexander Wree et al. HEPATOLOGY
- P2X7 blockade attenuates mouse liver fibrosis
- (2013) CHANGSHAN HUANG et al. Molecular Medicine Reports
- Interleukin-1β upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells
- (2013) NING TANG et al. Molecular Medicine Reports
- Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
- (2013) Laura J. Dixon et al. PLoS One
- Involvement of oxidative stress and immune- and inflammation-related factors in azathioprine-induced liver injury
- (2013) Kentaro Matsuo et al. TOXICOLOGY LETTERS
- IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease
- (2013) Amina A. Negash et al. PLoS Pathogens
- Current status of inflammasome blockers as anti-inflammatory drugs
- (2012) Gloria López-Castejón et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
- (2012) Vincent Compan et al. IMMUNITY
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
- (2012) Kenichi Shimada et al. IMMUNITY
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
- (2012) Jan Petrasek et al. JOURNAL OF CLINICAL INVESTIGATION
- Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
- (2012) Laura J Dixon et al. LABORATORY INVESTIGATION
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
- (2011) Nadia M. Luheshi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
- (2011) Derrick M. Van Rooyen et al. GASTROENTEROLOGY
- Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
- (2011) Yehuda Kamari et al. JOURNAL OF HEPATOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- Role of the Nalp3 inflammasome in acetaminophen-induced sterile inflammation and liver injury
- (2011) C. David Williams et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure
- (2010) Chunli Yan et al. LIVER INTERNATIONAL
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial
- (2009) Manal F. Abdelmalek et al. HEPATOLOGY
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease
- (2009) Noritaka Takatsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cutting Edge: NF- B Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
- (2009) F. G. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice
- (2008) Rebeca Salguero Palacios et al. LABORATORY INVESTIGATION
- RelA Ser276 Phosphorylation Is Required for Activation of a Subset of NF- B-Dependent Genes by Recruiting Cyclin-Dependent Kinase 9/Cyclin T1 Complexes
- (2008) D. E. Nowak et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started